# Hong Kong Critical Illness Cover vs Mainland Critical Illness Insurance: A Like-for-Like Comparison

> How Hong Kong critical illness policies differ from Mainland products: source of definitions (voluntary HKFI standard vs the mandatory 2020 specification of 28 severe and 3 mild conditions), the 30% mild-condition cap, incontestability, currency, underwriting, claims and dispute routes, and tax.

- URL: https://criticalillness.hk/en/compare/
- Author: Critical Illness Terms Review Editorial (https://criticalillness.hk/about/)
- Reviewed by: Critical Illness Terms Review Editorial Editorial Board
- Published: 2026-11-04
- Updated: 2026-11-04
- Language: en

## Key takeaways

- Mainland critical illness products must use the uniform definitions issued by the Insurance Association of China and the Chinese Medical Doctor Association on 5 November 2020 (28 severe and 3 mild conditions, transition ended 31 January 2021); Hong Kong definitions are set by each insurer, with a voluntary HKFI standard for 21 conditions from 1 September 2026.
- The Mainland specification caps mild-condition payouts at 30% of the basic sum insured and classifies thyroid cancer at TNM stage I or below as mild; Hong Kong early-stage percentages are set by each insurer, commonly 20% to 35%.
- Mainland insurance law extinguishes the insurer's right to rescind for non-disclosure 30 days after it learns of the ground and two years after the contract is formed; Hong Kong relies on utmost good faith with no statutory time limit.
- Hong Kong policies are denominated in HKD or USD and disputes go to the Insurance Complaints Bureau (limit HK$1.5 million) or Hong Kong courts; Mainland policies are in RMB under Mainland law.

## Two rule systems

Hong Kong critical illness cover and Mainland critical illness insurance insure the same risk under different rules. Mainland definitions are fixed by the Specification on the Use of Disease Definitions for Critical Illness Insurance (2020 revision), issued on 5 November 2020 by the Insurance Association of China and the Chinese Medical Doctor Association, with a transition period that ended on 31 January 2021; products based on the 2007 specification could not be sold after that date. Hong Kong has no statutory uniform definitions; each insurer drafts its own, and from 1 September 2026 the Hong Kong Federation of Insurers standardizes 21 definitions on a voluntary basis. Interpretation of Mainland rules should be taken from Mainland official texts.

## Comparison table

| Dimension | Hong Kong | Mainland |
|---|---|---|
| Source of definitions | Insurer's own wording; voluntary HKFI standard for 16 major + 5 minor conditions + ADL from 1 Sep 2026 | Mandatory 2020 specification: 28 severe + 3 mild conditions |
| Core conditions | No limit on scope; products commonly cover 60 to over 100 conditions | Products must include at least the first three severe conditions (severe malignant tumour, moderately severe acute myocardial infarction, severe sequelae of stroke) |
| Mild / early-stage | Insurer-set percentages, commonly 20%–35%; some conditions claimable twice | Three mild conditions capped at 30% of the basic sum insured |
| Thyroid cancer | Varies; early thyroid cancer often an early-stage condition at a lower percentage | TNM stage I or below classed as mild, maximum 30% |
| Multiple claims | By condition group, claim count, interval and total multiple (published examples 300%–700%) | Multi-pay products exist within the specification framework |
| Waiting period | Commonly 90 days; longer for some conditions; accidents usually exempt | Commonly 90 or 180 days per policy |
| Survival period | Commonly 14–30 days; some products none | Most products none (per policy) |
| Disclosure and incontestability | Utmost good faith; material non-disclosure can void the policy; no statutory time limit; some policies carry a contractual incontestability clause | Insurance Law article 16: rescission right lapses 30 days after the insurer learns of the ground and two years after contract formation |
| Underwriting | Insurer standards: standard, loading, exclusion, postponement, decline | Insurer standards; automated and manual underwriting |
| Currency | HKD or USD | RMB |
| Tax | No capital gains tax; claim proceeds not assessable to salaries tax; premiums not deductible | Insurance indemnities exempt under individual income tax law; treatment of bonuses per Mainland rules |
| Disputes | Insurer appeal → Insurance Complaints Bureau (HK$1.5 million limit, free) → Hong Kong courts | Insurer → regulatory complaint channels or mediation → arbitration or Mainland courts |
| Legal protection | Hong Kong law; Mainland residents must sign in Hong Kong and complete the IFS-MP | Mainland law; Hong Kong policies bought inside the Mainland are not protected by Mainland law |

## What the differences mean

**Definitions.** The 2020 specification expanded the 2007 list of 25 conditions to 28 severe conditions (adding severe chronic respiratory failure, severe Crohn's disease and severe ulcerative colitis), introduced three mild conditions, tightened the cancer definition with ICD-O coding and histopathology requirements, reclassified thyroid cancer at TNM stage I or below as mild, and relaxed coronary artery bypass surgery to include minimally invasive procedures that open the pericardium. Every Mainland product uses these definitions, so the 28 severe conditions are comparable across insurers. In Hong Kong the definitions are contract terms that genuinely differ; the 2026 HKFI standard narrows the gap for 21 conditions in new products but is voluntary and does not govern conditions outside the 21. A Hong Kong policy's "100 conditions" cannot be read against the Mainland "28 + 3"; the comparison that matters is the wording of the three core conditions.

**Mild conditions.** The Mainland cap is explicit: 30% of the basic sum insured. Hong Kong early-stage percentages are set by each insurer; published examples run 20% to 25%, with some products at 35% and some allowing two claims. Both markets usually deduct early payments from total cover; Hong Kong deduction and restoration rules are more complex.

**Incontestability.** This is the most substantive legal difference. Under Mainland Insurance Law article 16, the insurer's right to rescind for deliberate or grossly negligent non-disclosure lapses 30 days after it learns of the ground and in any case two years after the contract is formed. Hong Kong has no equivalent statute: the contract rests on utmost good faith, material non-disclosure allows avoidance, and the Complaints Panel applies its three-part test regardless of how long the policy has been in force (the cases cited on this site arose 14 months and over four years after application). Some Hong Kong policies include a contractual incontestability clause for the life benefit, usually excluding fraud and not necessarily extending to critical illness benefits. For Mainland applicants the Hong Kong duty of disclosure is therefore stricter and longer-lived.

**Currency and premiums.** Hong Kong policies are in HKD or USD; the IFS-MP requires Mainland applicants to acknowledge exchange-rate and policy risk. Claims that Hong Kong premiums are "20% to 30% cheaper" depend on age, sex, sum insured, benefit structure and savings content; this site cites no unverified percentage. Compare only after aligning sum insured, term and mild-condition structure.

**Claims and disputes.** Hong Kong claims are decided against the policy definition; disputes go first to the insurer, then to the Insurance Complaints Bureau (jurisdiction HK$1.5 million since 1 January 2025, free, rulings binding on insurers), then to Hong Kong courts. Mainland residents may complain to the Bureau but may need to attend in Hong Kong. In 2025 the Bureau closed 75 critical illness disputes, 52 on policy terms and 19 on non-disclosure. Mainland disputes follow Mainland law and channels.

## Who each suits

Residents of the Mainland with RMB income and expenses are covered by Mainland law and the Mainland medical system through Mainland products; a Hong Kong policy is a foreign-currency supplement that carries the cost of travelling to sign, foreign-currency premiums and a stricter disclosure duty. Residents of Hong Kong or people with HKD or USD income rely on Hong Kong cover. Families moving between the two are usually better served by one policy in each system than by treating either as a cross-border solution. Nobody should decide on the number of conditions covered; compare the three core definitions, the incontestability rule and the ability to keep disclosing and paying premiums over the life of the policy. This page recommends no product; both markets' rules and products change, and the latest documents of the Mainland regulator, the Hong Kong Insurance Authority and the HKFI prevail.

## Sources and dates

- Release of the Specification on the Use of Disease Definitions for Critical Illness Insurance (2020 revision) — China Securities Journal (reporting the Insurance Association of China and Chinese Medical Doctor Association release; secondary) 2020-11-05 https://cs.com.cn/xwzx/hg/202011/t20201105_6108694.html
- Explainer on the 2020 CI definition rules (thyroid cancer, bypass surgery, 30% cap) — PEdaily (secondary) 2020-12-18 https://news.pedaily.cn/20201218/9115.shtml
- Best Practice on Standardization of Critical Illness Definitions — Hong Kong Federation of Insurers (HKFI) 2026-03 https://ci-definitions.hkfi.org.hk/best-practice
- Will non-disclosure lead to rejection of claims? What must be disclosed? — Community Legal Information Centre (CLIC) 2026-11 https://www.clic.org.hk/en/topics/insurance/general_matters_concerning_all_types_of_insurance/q1
- ICB Annual Report 2025-2026 — Insurance Complaints Bureau (ICB) 2026-04 https://www.icb.org.hk/files/ar_2025_26.pdf

---

This site is run by Critical Illness Terms Review Editorial, an independent insurance information site providing general education and comparison. It is not an insurer, licensed insurance intermediary or bank, sells no insurance product and accepts no application. Content has not been reviewed, approved or endorsed by the Insurance Authority (IA). For applications, quotations and policy servicing, consult a Hong Kong insurer or licensed insurance intermediary.